CVA Family Office’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84.5K | Buy |
1,080
+276
| +34% | +$21.6K | 0.01% | 435 |
|
|
2025
Q1 | $58.3K | Sell |
804
-169
| -17% | -$12.2K | 0.01% | 493 |
|
|
2024
Q4 | $72K | Buy |
973
+799
| +459% | +$59.2K | 0.01% | 447 |
|
|
2024
Q3 | $11.5K | Sell |
174
-1,628
| -90% | -$107K | ﹤0.01% | 737 |
|
|
2024
Q2 | $166K | Sell |
1,802
-85
| -5% | -$7.85K | 0.03% | 267 |
|
|
2024
Q1 | $180K | Hold |
1,887
| – | – | 0.03% | 262 |
|
|
2023
Q4 | $144K | Buy |
+1,887
| New | +$144K | 0.03% | 283 |
|
|
2023
Q3 | – | Sell |
-2,199
| Closed | -$207K | – | 469 |
|
|
2023
Q2 | $207K | Buy |
2,199
+8
| +0.4% | +$755 | 0.04% | 218 |
|
|
2023
Q1 | $181K | Buy |
+2,191
| New | +$181K | 0.04% | 231 |
|
|
2022
Q4 | – | Sell |
-1,624
| Closed | -$134K | – | 967 |
|
|
2022
Q3 | $134K | Sell |
1,624
-1,190
| -42% | -$98.2K | 0.04% | 210 |
|
|
2022
Q2 | $268K | Buy |
2,814
+695
| +33% | +$66.2K | 0.07% | 140 |
|
|
2022
Q1 | $249K | Buy |
2,119
+340
| +19% | +$40K | 0.06% | 157 |
|
|
2021
Q4 | $230K | Buy |
1,779
+1,074
| +152% | +$139K | 0.06% | 159 |
|
|
2021
Q3 | $56K | Sell |
705
-1,364
| -66% | -$108K | 0.04% | 171 |
|
|
2021
Q2 | $214K | Buy |
2,069
+939
| +83% | +$97.1K | 0.06% | 152 |
|
|
2021
Q1 | $95K | Buy |
1,130
+425
| +60% | +$35.7K | 0.04% | 184 |
|
|
2020
Q4 | $64K | Hold |
705
| – | – | 0.04% | 165 |
|
|
2020
Q3 | $56K | Buy |
705
+405
| +135% | +$32.2K | 0.04% | 171 |
|
|
2020
Q2 | $21K | Buy |
+300
| New | +$21K | 0.02% | 216 |
|